Structural insights into amyloid structures of the C-terminal region of nucleophosmin 1 in type A mutation of acute myeloid leukemia.


Journal

Biochimica et biophysica acta. Proteins and proteomics
ISSN: 1878-1454
Titre abrégé: Biochim Biophys Acta Proteins Proteom
Pays: Netherlands
ID NLM: 101731734

Informations de publication

Date de publication:
06 2019
Historique:
received: 17 11 2018
revised: 11 01 2019
accepted: 26 01 2019
pubmed: 3 2 2019
medline: 23 10 2019
entrez: 3 2 2019
Statut: ppublish

Résumé

Acute myeloid leukemia (AML) is a clinically and a molecularly heterogeneous disease characterized by the accumulation of undifferentiated and uncontrolled proliferation of hematopoietic progenitor cells. The sub-group named "AML with gene mutations" includes mutations in nucleophosmin (NPM1) assumed as a distinct leukemic entity. NPM1 is an abundant multifunctional protein belonging to the nucleoplasmin family of nuclear chaperones. AML mutated protein is translocated into the cytoplasm (NPM1c+) retaining all functional domains except the loss of a unique NoLs (nucleolar localization signal) at the C-term domain (CTD) and the subsequent disruption of a three helix bundle as tertiary structure. The oligomeric state of NPM1 is of outmost importance for its biological roles and our previous studies linked an aggregation propensity of distinct regions of CTD to leukomogenic potentials of AML mutations. Here we investigated a polypeptide spanning the third and second helices of the bundle of type A mutated CTD. By a combination of several techniques, we ascertained the amyloid character of the aggregates and of fibrils resulting from a self-recognition mechanism. Further amyloid assemblies resulted cytoxic in MTT assay strengthening a new idea of a therapeutic strategy in AML consisting in the self-degradation of mutated NPM1.

Identifiants

pubmed: 30710643
pii: S1570-9639(19)30022-6
doi: 10.1016/j.bbapap.2019.01.010
pii:
doi:

Substances chimiques

NPM1 protein, human 0
Nuclear Proteins 0
Protein Aggregates 0
Nucleophosmin 117896-08-9

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

637-644

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Concetta Di Natale (C)

Department of Pharmacy, University of Naples "Federico II", Italy; Center for Advanced Biomaterial for Health Care (CABHC), Istituto Italiano di Tecnologia, Naples, Italy.

Sara La Manna (S)

Department of Pharmacy, University of Naples "Federico II", Italy.

Anna Maria Malfitano (AM)

Department of Translational Medicine, University of Naples "Federico II", Italy.

Sarah Di Somma (S)

Department of Translational Medicine, University of Naples "Federico II", Italy.

Daniele Florio (D)

Department of Pharmacy, University of Naples "Federico II", Italy.

Pasqualina Liana Scognamiglio (PL)

Center for Advanced Biomaterial for Health Care (CABHC), Istituto Italiano di Tecnologia, Naples, Italy.

Ettore Novellino (E)

Department of Pharmacy, University of Naples "Federico II", Italy.

Paolo Antonio Netti (PA)

Center for Advanced Biomaterial for Health Care (CABHC), Istituto Italiano di Tecnologia, Naples, Italy.

Daniela Marasco (D)

Department of Pharmacy, University of Naples "Federico II", Italy. Electronic address: daniela.marasco@unina.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH